Masatoshi Muramoto

904 total citations
15 papers, 558 citations indexed

About

Masatoshi Muramoto is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Masatoshi Muramoto has authored 15 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Masatoshi Muramoto's work include Renal cell carcinoma treatment (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Renal and related cancers (5 papers). Masatoshi Muramoto is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Renal and related cancers (5 papers). Masatoshi Muramoto collaborates with scholars based in Japan and United States. Masatoshi Muramoto's co-authors include Makoto Ohori, Thomas M. Wheeler, Shahrokh F. Shariat, Kevin M. Slawin, Michael W. Kattan, Peter T. Scardino, Norio Maru, Victor E. Reuter, Hideshige Koh and Τοyoaki Uchida and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Masatoshi Muramoto

15 papers receiving 548 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Masatoshi Muramoto	419	120	112	93	82	15	558
Thomas Cangiano	528 1.3×	133 1.1×	130 1.2×	77 0.8×	147 1.8×	11	641
Alan W Partin	483 1.2×	80 0.7×	192 1.7×	56 0.6×	72 0.9×	8	560
Brigitte Brux	389 0.9×	195 1.6×	90 0.8×	65 0.7×	57 0.7×	33	649
Claartje Gosselaar	578 1.4×	63 0.5×	122 1.1×	70 0.8×	158 1.9×	23	662
A.V. D’Amico	812 1.9×	85 0.7×	157 1.4×	105 1.1×	157 1.9×	16	924
Alice S. Whittemore	707 1.7×	66 0.6×	214 1.9×	58 0.6×	188 2.3×	5	850
Dennis L. Broyles	809 1.9×	166 1.4×	131 1.2×	183 2.0×	138 1.7×	17	1.0k
Chris Bangma	336 0.8×	80 0.7×	30 0.3×	72 0.8×	122 1.5×	28	547
Lorenzo Tosco	629 1.5×	154 1.3×	133 1.2×	143 1.5×	143 1.7×	42	751
Haluk Özen	492 1.2×	75 0.6×	186 1.7×	37 0.4×	186 2.3×	45	623

Countries citing papers authored by Masatoshi Muramoto

Since Specialization

Citations

This map shows the geographic impact of Masatoshi Muramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Muramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Muramoto more than expected).

Fields of papers citing papers by Masatoshi Muramoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Muramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Muramoto. The network helps show where Masatoshi Muramoto may publish in the future.

Co-authorship network of co-authors of Masatoshi Muramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Muramoto. A scholar is included among the top collaborators of Masatoshi Muramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Muramoto. Masatoshi Muramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fujita, Tetsuo, Masatsugu Iwamura, Nobuyuki Yanagisawa, et al.. (2008). Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma. International Journal of Urology. 15(7). 582–586. 9 indexed citations

Fujita, Tetsuo, Masatsugu Iwamura, Nobuyuki Yanagisawa, et al.. (2007). Prognostic Impact of Perirenal Fat or Adrenal Gland Involvement in Patients with pT3b Renal Cell Carcinoma. Urology. 69(5). 839–842. 7 indexed citations

Tabata, Ken‐ichi, Takefumi Satoh, Kazumasa Matsumoto, et al.. (2006). 8-MONTH NEOADJUVANT HORMONAL THERAPY BEFORE RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER. The Japanese Journal of Urology. 97(5). 712–718. 1 indexed citations

Hirayama, Takahiro, Kazumasa Matsumoto, Masatoshi Muramoto, et al.. (2006). [A case report: small cell carcinoma transformed from transitional cell carcinoma of the urinary bladder].. PubMed. 52(8). 633–5. 1 indexed citations

Ohori, Makoto, Michael W. Kattan, Hideshige Koh, et al.. (2004). Predicting the Presence and Side of Extracapsular Extension: A Nomogram for Staging Prostate Cancer. The Journal of Urology. 171(5). 1844–1849. 235 indexed citations

Kattan, Michael W., Shahrokh F. Shariat, Ben Andrews, et al.. (2003). The Addition of Interleukin-6 Soluble Receptor and Transforming Growth Factor Beta₁ Improves a Preoperative Nomogram for Predicting Biochemical Progression in Patients With Clinically Localized Prostate Cancer. Journal of Clinical Oncology. 21(19). 3573–3579. 156 indexed citations

Matsumoto, Kazumasa, Masatsugu Iwamura, Masatoshi Muramoto, et al.. (2002). PROGNOSTIC VALUE OF SERUM IMMUNOSUPPRESSIVE ACIDIC PROTEIN IN RENAL CELL CARCINOMA. The Japanese Journal of Urology. 93(4). 548–554. 5 indexed citations

Koh, Hideshige, Norio Maru, Masatoshi Muramoto, et al.. (2002). THE 1992 TNM CLASSIFICATION OF T2 PROSTATE CANCER PREDICTS PATHOLOGIC STAGE AND PROGNOSIS BETTER THAN THE REVISED 1997 CLASSIFICATION. The Japanese Journal of Urology. 93(5). 595–601. 1 indexed citations

Uchida, Τοyoaki, Chunxi Wang, Masatoshi Muramoto, et al.. (2002). Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma. Urology. 59(4). 615–620. 42 indexed citations

10.

Uchida, Τοyoaki, Jiangping Gao, Chunxi Wang, et al.. (2001). Antitumor Effect of bcl-2 Antisense Phosphorothioate Oligodeoxynucleotides on Human Renal-Cell Carcinoma Cells in Vitro and in Mice. PubMed. 5(2). 71–78. 14 indexed citations

11.

Iwamura, Masatsugu, Weicheng Wu, Masatoshi Muramoto, et al.. (1999). Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma. Cancer. 86(6). 1028–1034. 31 indexed citations

12.

Uchida, Τοyoaki, et al.. (1998). Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. Urology. 52(1). 66–71. 51 indexed citations

13.

Muramoto, Masatoshi, Takefumi Uchida, Junnosuke Ishii, et al.. (1996). [A case of solitary metastasis from renal cell carcinoma to the thyroid gland].. PubMed. 42(2). 123–5. 2 indexed citations

14.

Iwamura, Masatsugu, et al.. (1996). [A case of spontaneous rupture of renal leiomyosarcoma].. PubMed. 42(8). 583–6. 2 indexed citations

15.

Muramoto, Masatoshi, et al.. (1994). [A case of renal oncocytoma].. PubMed. 40(1). 47–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact